CLS vs. SANM: Which Stock is Better Positioned for the AI Boom?
Celestica (CLS) and Sanmina (SANM) are EMS providers benefiting from AI and cloud computing growth. Sanmina reported Q3 2026 revenue of $3.46B (+69.7% YoY), driven by AI infrastructure demand. Celestica reported Q3 2026 revenue of $5.83B (+82.5% YoY), with strong growth in networking and computing. Both face competitive pressures and execution challenges. Analysts expect significant growth for both companies, with CLS trading at a higher P/E ratio than SANM.
How this was made

The 30-second read
Why it matters
Both companies show strong top‑line growth, but differing profitability and cash‑flow profiles suggest divergent short‑term price reactions.
Market read
The earnings release provides fresh data for traders to assess relative positioning in the AI‑driven EMS sector.
What to watch
Potential supply‑chain bottlenecks and rising component costs could temper growth for both EMS providers.
Background
The article compares Q3 2026 earnings and growth metrics of two EMS leaders, Celestica and Sanmina, within the context of the expanding AI and cloud computing market.
Ticker impact
Celestica reported Q3 2026 revenue of $5.83B, 82.5% YoY growth and EPS of $3.3, beating estimates.
likely upward pressure as investors price in earnings beat and margin expansion
Revenue and earnings both surged well above prior year; margins hit record high, suggesting continued momentum.
Sanmina posted Q3 2026 revenue of $3.46B, up 69.7% YoY, but free cash flow was only $24M amid high inventory.
potential pressure as market weighs strong top‑line growth against weak cash flow
Revenue growth is impressive, yet thin free cash flow and high inventory may limit near‑term buying.
Market effects
Both firms highlight accelerating demand for AI‑related EMS services, reinforcing bullish outlook for the broader electronics manufacturing sector.
North American EMS players may see increased investor interest as AI infrastructure spending rises.
The AI boom narrative extends globally, but the immediate impact centers on U.S. listed EMS stocks.
Counterpoint
Sanmina's cash‑flow constraints could outweigh its revenue surge, making CLS the more attractive play despite higher valuation.
Key entities
- CompanyCelestica Inc.
U.S.-listed EMS provider (ticker CLS) reporting strong Q3 earnings.
- CompanySanmina Corporation
U.S.-listed EMS provider (ticker SANM) reporting robust revenue but weak cash flow.



